STAT+: After warning letter, Whoop and FDA in discussions about controversial blood pressure feature
Whoop is currently in discussions with the FDA regarding a blood pressure feature that the agency claims requires regulatory review. The FDA previously warned Whoop that the feature, which estimates users' blood pressure, is classified as a medical device. Whoop contends that the feature is intended for wellness purposes and should be exempt from such review.
- ▪The FDA warned Whoop last July that its blood pressure feature requires regulatory review.
- ▪Whoop argues that the feature is for wellness purposes and should be exempt from FDA oversight.
- ▪In January, the FDA updated its guidance on wellness products to include blood pressure information.
STAT News files mainly under health. We currently carry 235 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | STAT |
| Canonical URL | https://www.statnews.com/2026/05/21/whoop-has-not-resolved-fda-dispute-over-blood-pressure-feature/?utm_campaign=rss |
| Publication time | Thu, 21 May 2026 08:30:00 +0000 |
| Retrieval time | 2026-05-21T08:38:14.816Z |
| Last seen | 2026-05-21T09:03:51.168Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | _r8j_1vSnumx |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
STAT PlusHealth tech After warning letter, Whoop and FDA in discussions about controversial blood pressure feature The agency warned Whoop last July that the feature required regulatory review Manage alerts for this article Email this article Share this article Ricky Bloomfield, chief medical officer at Oura (left), and Alex Vannoni, head of health care products at Whoop, participate in a session on wearables at the Breakthrough Summit West.Jack Simpson for STAT By Mario AguilarMay 21, 2026 Health Tech Correspondent Mario Aguilar[email protected]Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer wearables.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at STAT.
Discussion
0 commentsMore from STAT
